Literature DB >> 30291317

Lifestyle interventions to prevent cognitive impairment, dementia and Alzheimer disease.

Miia Kivipelto1,2,3,4, Francesca Mangialasche5,6, Tiia Ngandu7,5.   

Abstract

Research into dementia prevention is of paramount importance if the dementia epidemic is to be halted. Observational studies have identified several potentially modifiable risk factors for dementia, including hypertension, dyslipidaemia and obesity at midlife, diabetes mellitus, smoking, physical inactivity, depression and low levels of education. Randomized clinical trials are needed that investigate whether interventions targeting these risk factors can reduce the risk of cognitive decline and dementia in elderly adults, but such trials are methodologically challenging. To date, most preventive interventions have been tested in small groups, have focused on a single lifestyle factor and have yielded negative or modest results. Given the multifactorial aetiology of dementia and late-onset Alzheimer disease, multidomain interventions that target several risk factors and mechanisms simultaneously might be necessary for an optimal preventive effect. In the past few years, three large multidomain trials (FINGER, MAPT and PreDIVA) have been completed. The FINGER trial showed that a multidomain lifestyle intervention can benefit cognition in elderly people with an elevated risk of dementia. The primary results from the other trials did not show a statistically significant benefit of preventive interventions, but additional analyses among participants at risk of dementia showed beneficial effects of intervention. Overall, results from these three trials suggest that targeting of preventive interventions to at-risk individuals is an effective strategy. This Review discusses the current knowledge of lifestyle-related risk factors and results from novel trials aiming to prevent cognitive decline and dementia. Global initiatives are presented, including the World Wide FINGERS network, which aims to harmonize studies on dementia prevention, generate high-quality scientific evidence and promote its implementation.

Entities:  

Mesh:

Year:  2018        PMID: 30291317     DOI: 10.1038/s41582-018-0070-3

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN: 1759-4758            Impact factor:   42.937


  177 in total

1.  Shared genetic architecture between metabolic traits and Alzheimer's disease: a large-scale genome-wide cross-trait analysis.

Authors:  Zhaozhong Zhu; Yifei Lin; Xihao Li; Jane A Driver; Liming Liang
Journal:  Hum Genet       Date:  2019-02-25       Impact factor: 4.132

Review 2.  Is Alzheimer's Disease Risk Modifiable?

Authors:  Alberto Serrano-Pozo; John H Growdon
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

Review 3.  Cognitive benefits of exercise interventions: an fMRI activation likelihood estimation meta-analysis.

Authors:  Qian Yu; Fabian Herold; Benjamin Becker; Ben Klugah-Brown; Yanjie Zhang; Stephane Perrey; Nicola Veronese; Notger G Müller; Arthur F Kramer; Liye Zou
Journal:  Brain Struct Funct       Date:  2021-03-06       Impact factor: 3.270

Review 4.  [Dementia: relevant aspects for otorhinolaryngologists].

Authors:  R Dodel; C Völter
Journal:  HNO       Date:  2020-03       Impact factor: 1.284

5.  Alzheimer's disease: A clinical perspective and future nonhuman primate research opportunities.

Authors:  Rafi U Haque; Allan I Levey
Journal:  Proc Natl Acad Sci U S A       Date:  2019-12-23       Impact factor: 11.205

6.  27-Hydroxycholesterol Alters Synaptic Structural and Functional Plasticity in Hippocampal Neuronal Cultures.

Authors:  Yushan Wang; Yu An; Dandi Zhang; Huiyan Yu; Xiaona Zhang; Ying Wang; Lingwei Tao; Rong Xiao
Journal:  J Neuropathol Exp Neurol       Date:  2019-03-01       Impact factor: 3.685

Review 7.  Mitochondrial dynamics and transport in Alzheimer's disease.

Authors:  Padraig J Flannery; Eugenia Trushina
Journal:  Mol Cell Neurosci       Date:  2019-06-16       Impact factor: 4.314

Review 8.  Dopaminergic Pathways in Obesity-Associated Inflammation.

Authors:  Fernanda Leite; Laura Ribeiro
Journal:  J Neuroimmune Pharmacol       Date:  2019-07-17       Impact factor: 4.147

9.  Long-Term Trajectories of Body Weight, Diet, and Physical Activity From Midlife Through Late Life and Subsequent Cognitive Decline in Women.

Authors:  Maude Wagner; Francine Grodstein; Cécile Proust-Lima; Cécilia Samieri
Journal:  Am J Epidemiol       Date:  2020-04-02       Impact factor: 4.897

10.  The Association of Osteoarthritis and Related Pain Burden to Incident Alzheimer's Disease and Related Dementias: A Retrospective Cohort Study of U.S. Medicare Beneficiaries.

Authors:  Kim E Innes; Usha Sambamoorthi
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.